Grob et al raise some valid points regarding the methodological limitations of our findings, which we ourselves had attempted to acknowledge, both in the "Comment" section and in our characterization of our results as "preliminary observations." There are, however, several other issues raised by Grob et al on which we offer the following comments:1. Urine toxicology by enzyme immunoassay (EMIT) was obtained on all subjects on the morning of the intravenous L-tryptophan test, immediately prior to beginning the test. Although inadvertently omitted from the final draft of the article, these screens revealed no evidence of recent use of psychoactive drugs. However, most of our subjects did have a past history of use of illicit psychoactive drugs; as Grob et al imply, we cannot state with certainty that use of these other drugs did not account for or contribute to the altered responses to L-tryptophan. The fact is,
Price LH, Krystal JH, Heninger GR, Ricaurte GA. Second Thoughts on 3,4-Methylenedioxymethamphetamine (MDMA) Neurotoxicity-Reply. Arch Gen Psychiatry. 1990;47(3):289. doi:10.1001/archpsyc.1990.01810150089015
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: